Special issue on inflammation and liver diseases
Published 30 May, 2022
The liver is an essential metabolic organ regulating plasma protein synthesis, gluconeogenesis, glycogen storage, cholesterol metabolism, bile acid synthesis, drug metabolism and detoxification. Liver fibrosis, cirrhosis, liver failure and even liver cancer are the most common forms of liver disease progression and prognosis. As many studies have now demonstrated that most liver injuries are accompanied by inflammatory reactions, understanding the relationship between the two is a critical step towards carrying out targeted treatment to prevent disease progression and improve patients’ quality of life.
This special issue will present research related to liver disease and inflammation to greatly improve our understanding of their mechanisms and drive the development of novel and effective treatments in a clinical setting. We welcome original research and review articles, along with case reports related to novel therapies that help to expand our knowledge and improve the accuracy and efficiency of the diagnosis and treatment of liver diseases.
- Non-alcoholic fatty liver diseases and alcoholic liver diseases
- Alcoholic hepatitis
- Liver failure
- Liver cancer
- Submission deadline: 30 November 2022
- Publication date: 30 December 2022
Please read the Guide for Authors before submitting. All articles should be submitted online; please select Special issue on inflammation and liver diseases on submission.
- Prof. Hua Wang, Anhui Medical University, China. Email: email@example.com